Knockdown of spinal cord postsynaptic density protein-95 prevents the development of morphine tolerance in rats

Neuroscience

Volumn 123, Issue 1, 2004, Pages 11-15

  Liaw, W J ^a,b   Zhang, B ^a,c   Tao, F ^a   Yaster, M ^a   Johns, R A ^a   Tao, Y X ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Antisense technology; Hyperalgesia; Intrathecal injection; NMDA receptors; Opioid tolerance

Indexed keywords

MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; MOLECULAR DYNAMICS; MORPHINE TOLERANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; SPINAL CORD; THERMAL STIMULATION;

EID: 0344255683     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.09.007     Document Type: Article

References (32)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., Tymianski M. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science. 298:2002;846-850.
2. Bederson J.B., Fields H.L., Barbaro N.M. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedulla medulla. Somatosens Mot Res. 7:1990;185-203.
3. Carroll R.C., Zukin R.S. NMDA-receptor trafficking and targeting implications for synaptic transmission and plasticity . Trends Neurosci. 25:2002;571-577.
4. Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem. 274:1999;27467-27473.
5. Garry E.M., Moss A., Delaney A., O'Neill F., Blakemore J., Bowen J., Husi H., Mitchell R., Grant S.G., Fleetwood-Walker S.M. Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD-95 mutant mice. Curr Biol. 18:2003;321-328.
6. Kornau H.-C., Schenker L.T., Kennedy M.B., Seeburg P.H. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science. 269:1995;1737-1740.
7. Kumar S., Bhargava H.N. Time course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse reversal by naltrexone . Gen Pharmacol. 29:1997;223-227.
8. Imamura F., Maeda S., Doi T., Fujiyoshi Y. Ligand binding of the second PDZ domain regulates clustering of PSD-95 with the Kv1.4 potassium channel. J Biol Chem. 277:2002;3640-3646.
9. Machelska H., Ziólkowska B., Mika J., Przewlocka B., PrzewlockiCA R. Chronic morphine increases biosynthesis of nitric oxide synthase in the rat spinal cord. Neuroreport. 8:1997;2743-2747.
10. Manning B.H., Mao J., Frenk H., Price D.D., Mayer D.J. Continuous co-administration of dextromethorphan or MK-801 with morphine attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance . Pain. 67:1996;79-88.
11. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats roles of excitatory amino acid receptors and protein kinase C . J Neurosci. 14:1994;2301-2312.
12. Mao J., Price D.D., Phillips L.L., Lu J., Mayer D.J. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res. 677:1995;257-267.
13. Marek P., Ben Eliyahu S., Vaccarino A.L., Liebeskind J.C. Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res. 558:1991;163-165.
14. Martin W.R. Opioid antagonists. Pharmacol Rev. 19:1967;463-521.
15. Melzack R. The tragedy of needless pain. Sci Am. 262:1990;27-33.
16. Migaud M., Charlesworth P., Dempster M., Webster L.C., Watabe A.M., Makhinson M., He Y., Ramsay M.F., Morris R.G., Morrison J.H., O'Dell T.J., Grant S.G. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature. 396:1998;433-439.
17. Ozek M., Uresin Y., Gungor M. Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice. Life Sci. 72:2003;1943-1951.
18. Powell K.J., Abul-Husn N.S., Jhamandas A., Olmstead M.C., Beninger R.J., Jhamandas K. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther. 300:2002;588-596.
19. Powell K.J., Hosokawa A., Bell A., Sutak M., Milne B., Quirion R., Jhamandas K. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol. 127:1999;631-644.
20. Raghavendra V., Kulkarni S.K. Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. Eur J Pharmacol. 409:2000;279-289.
21. Roche K.W., Standley S., McCallum J., Dune Ly C., Ehlers M.D., Wenthold R.J. Molecular determinants of NMDA receptor internalization. Nat Neurosci. 4:2001;794-802.
22. Sattler R., Xiong Z., Lu W.Y., Hafner M., MacDonald J.F., Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 284:1999;1845-1848.
23. Tanemoto M., Fujita A., Higashi K., Kurachi Y. PSD-95 mediates formation of a functional homomeric Kir5.1 channel in the brain. Neuron. 34:2002;387-397.
24. Tao F., Tao Y.-X., Gonzalez J.A., Fang M., Mao P., Johns R.A. Knockdown of PSD-95/SAP90 delays the development of neuropathic pain in rats. Neuroreport. 12:2001;3251-3255.
25. Tao F., Tao Y.-X., Mao P., Johns R.A. Role of postsynaptic density protein-95 in the maintenance of peripheral nerve injury-induced neuropathic pain in rats. Neuroscience. 117:2003;731-739.
26. Tao Y.-X., Hassan A., Haddad E., Johns R.A. Expression and action of cyclic GMP-dependent protein kinase Iα in inflammatory hyperalgesia in rat spinal cord. Neuroscience. 95:2000;525-533.
27. Tao Y.-X., Huang Y.Z., Mei L., Johns R.A. Expression of PSD-95/SAP90 is critical for N-methyl-D-aspartate receptor-mediated thermal hyperalgesia in the spinal cord. Neuroscience. 98:2000;201-206.
28. Tao Y.-X., Johns R.A. Effect of the deficiency of spinal psd-95/sap90 on the minimum alveolar anesthetic concentration of isoflurane in rats. Anesthesiology. 94:2001;1010-1015.
29. Tao Y.-X., Johns R.A. Activation and up-regulation of spinal cord nitric oxide receptor, soluble guanylate cyclase, after formalin injection into the rat hind paw. Neuroscience. 112:2002;439-446.
30. Tao Y.-X., Rumbaugh G., Wang G.-D., Petralia R.S., Zhao C., Kauer F., Tao F., Zhuo M., Wenthold R.J., Raja S.N., Huganir R.L., Bredt D.S., Johns R.A. Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking PSD-93. J Neurosci. 23:2003;6703-6712.
31. Yaksh T.L., Rudy T.A. Analgesia mediated by a direct spinal action of narcotics. Science. 192:1976;1357-1358.
32. Zhao G.M., Bhargava H.N. Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [D-Ala2, Glu4] deltorphin II, a delta 2-opioid receptor agonist in mice. Peptides. 17:1996;619-623.